SNCA and Parkinson disease: Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta and the accumulation of Lewy pathology composed largely of misfolded α-synuclein [1, 2].